Posted on 10 月 12, 202210/12/22
Benchmarking Your Specialty Brand’s Rx Pull-Through Against Competitors In and Out of Your Network
Posted on 9 月 19, 20229/19/22
How Specialty Pharmacies Can Elevate Your Channel and Distribution Strategy for HCP-administered Buy & Bill Products
Posted on 9 月 14, 20229/14/22
AMA Scheduled to Deliberate Potential Approval of Additional Digital Medicine CPT Codes
Posted on 9 月 13, 20229/13/22
Reimbursement Landscape for Digital Medicine Continues to Advance with CMS
Posted on 7 月 27, 20227/27/22
EVERSANA’s Continued Commitment to Rare Disease
Posted on 6 月 28, 20226/28/22
Evolution of Integrated Mental Health Treatment Models in Southeast Asia (SEA)
Posted on 5 月 24, 20225/24/22
Overcome In-Licensing Barriers to Increase Throughput of Assets
Posted on 4 月 8, 20224/8/22
EVERSANA Featured in NIH Study Detailing the Cost of Treating Rare Disease
Posted on 4 月 7, 20224/7/22